Ionis Pharmaceuticals Inc (IONS) stock is down -33.26% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives IONS stock a score of 30 out of a possible 100. That rank is primarily influenced by a long-term technical score of 8. IONS's rank also includes a short-term technical score of 10. The fundamental score for IONS is 72. In addition to the average rating from Wall Street analysts, IONS stock has a mean target price of $49.41. This means analysts expect the stock to rise 56.85% over the next 12 months.
IONS has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on IONS!